Maternal issues affecting the fetus

Clinics in Perinatology

Volumn 28, Issue 1, 2001, Pages 31-70

  Shillingford, Amanda J ^a   Weiner, Stuart ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; FOLIC ACID; INDOMETACIN; ISOTRETINOIN; LITHIUM; MABARAL; MEPHENYTOIN; MESUXIMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PERGANONE; PHENOBARBITAL; PHENSUXIMIDE; PHENYTOIN; PRIMIDONE; PROPRANOLOL; PROPYLTHIOURACIL; RETINOIC ACID; RETINOL; RETINOL DERIVATIVE; RUBELLA VACCINE; TERBUTALINE; THIAMAZOLE; UTERUS SPASMOLYTIC AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; ZERONTIN;

CONGENITAL DISORDER; CONGENITAL HEART BLOCK; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; FETUS; FETUS DISEASE; FETUS MALFORMATION; FETUS MONITORING; GENETIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIA; HYPERTHYROIDISM; INFLUENZA; INTRAUTERINE INFECTION; LUPUS ERYTHEMATOSUS; LYME DISEASE; MATERNAL DIABETES MELLITUS; MATERNAL DISEASE; METABOLIC DISORDER; MUMPS; NEUROFIBROMATOSIS; PARVOVIRUS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; RUBELLA; SYPHILIS; TERATOGENICITY; TOXOPLASMOSIS;

EID: 0035101007     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70069-5     Document Type: Article

References (235)

1. Premature closure of the fetal ductus arteriosus after maternal use of non-streroidal anti-inflammatory drugs
2. Congenital and perinatal cytomegalovirus infections
3. Common viral infections
4. Human parvovirus
5. Genetic counseling in congenital heart disease
6. Coxsackie virus B3 calcific pancarditis and hydrops fetalis
7. Randomized comparative trial of indomethacin and ritrodine for the long term treatment of preterm labor
8. High grade atrioventricular heart block in an adult with SLE: The association of nuclear RNP(U1RNP) antibodies, a case report and review of the literature
9. Cardiac involvement in inherited disorders of metabolism
10. Focal necrosis, fatty degeneration and subendocardial nuclear polyploidization of the myocardium in newborns after sympathomimetic suppression of premature labor
11. Familial risks of congenital heart defects assessed in a population-based epidemiologic study
12. Electrophysiologic characterization of purified IgG from a mother whose child has congenital heart block (CHB) on L-type calcium currents (Ica)
13. Toxoplasmosis
14. Maternal illness in pregnancy
15. Cardiac septal hypertrophy in hyperinsulinemic infant
16. Somatomedins and other growth factors in fetal growth
17. Cardiac complications of ritrodine in mother and baby
18. Interstitial and coxsackievirus B myocarditis in infants and children
19. Recurrence risks in offspring of adults with major heart defects: Results from first cohort of Britich collaborative study
20. The management of thyrotoxicosis in pregnancy
21. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity, and recurrence rates obtained from a national lupus registry
22. In utero identification and therapy of CHB
23. Congenital complete heart block: A human model of passively acquired autoimmune injury
24. Obstertrical outcomes of pregnancy in patients with systemic lupus erythematosus: A study of 60 cases
25. Alcohol consumption among pregnant and childbearing-aged women - United States, 1991-1995
26. Primary and secondary syphilis - United States 1997
27. Rubella and the congenital rubella syndrome - United States 1994-1997
28. Update: Frequent alcohol consumption among women of childbearing age - Behaviors risk factor surveillance system, 1991
29. Mumps virus
30. Pathogenetic mechanisms of congenital cardiovascular malformations revisisted
31. Persistant responsiveness of the neonatal ductus arteriosus in immature lambs: A possible cause for reopening of patent ductus arteriosus after indomethacin induced closure
32. The prevalence of antibody to human parvovirus B19 in England and Wales
33. A reevaluation of risk of in utero exposure to lithium
34. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
35. Assymetric spetal hypertrophy in infants of diabetic mothers: Fetal echocardiography and the impact of maternal diabetic control
36. Successful in utero therapy of fetal heart block
37. Infant of the diabetic mother
38. Anticonvulsants, folate levels, and pregnancy outcome: A prospective study
39. Thyrotoxicosis complicating pregnancy
40. The fetal valproate syndrome
41. Is there a genetic relationship between epilepsy and birth defects?
42. Treatment of thyroid disease in pregnancy
43. Ebstein's anomaly and maternal lithium exposure during pregnancy
44. The epidemiology of diabetes and pregnancy int the U.S., 1988
45. TORCH syndrome
46. Can fetal loss be prevented? The biochemical basis of diabeteic embryopathy
47. Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods
48. Ethyl alcohol induced cardiovascular malformations in the chick embryo
49. Congenital cardiovascular malformations: Questions on inheritance
50. Risk factors analysis: A synthetic
51. Congenital heart disease: Prevalence at livebirth - The Baltimore-Washington Infant Study
52. Lithium in pregnancy
53. Teratogenic drugs
54. Pregnancy as a tissue culture experience: The critical implications of maternal metabolism for fetal development
55. Fetal cardiac effects of oral ritrodine tocolysis
56. Facial clefts and congenital heart defects in children of parents with epilepsy: Genetic and environmental etiologic factors
57. Congenital heart defects in live-born children of epileptic parents
58. Transient electrocardiographic changes suggesting myocardial ischemia in newborn infants following tocolysis with beta-sympathomimetics
59. Endocardial fibroelastosis and the mumps virus
60. Fetal echocardiographic screening of diabetic pregnancies for congenital heart disease
61. Brief clinical report - Choanal atresia and athelia: Methimazole teratogenecity or a new syndrome?
62. First-trimester hemoglobin A1 and risk for major malformtion and spontaneous abortion in diabetic pregnancy
63. Rubella
64. Human B10 parvovirus infection in an obstetric population
65. Characterization of the cardiomyopathy in infants of diabetic mothers
66. Syphillis
67. Congenital cytomegalovirus infection: A long standing problem still seeking a solution
68. Hypertrophic cardiomyopathy in infants of poorly controlled diabetic mothers
69. AIDS and other acquired immunodeficiency diseases
70. Risks to offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome
71. Evaluation of vitamin A toxicity
72. Neonatal supraventricular tachycardia following prolonged maternal ritrodine administration
73. Social class, complications, and perinatal deaths in pregnancies of epileptic women: Preliminary results of the prospective Helsinki study
74. Serum folate concentrations during pregnancy in women with epilepsy: Relation to antiepileptic drug concentrations, number of seizures, and fetal outcome
75. A simple method to identify alcohol and other drug use in pregnant adults in prenatal settings
76. Prenatal complications
77. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block
78. Epidemiology, clinical features and prognostic factors of paediatric HIV infection
79. Prospective multicenter study of pregnancy outcome after lithium exposure during first trimester
80. Recognition of the fetal alcohol syndrome in early infancy
81. Immune-mediated congenital heart block (CHB): Identifying and counseling patients at risk for having children with CHB
82. Isolated congenital heart block: Fetal and infant outcome and familial incidence of heart block
83. Comment on teratogen update: Lithium
84. Fetal heart block associated with congenital cytomegalovirus infection: A case report
85. Beta-adrenergic tocolyis and effects on the heart of fetus and neonate: A review
86. Vitamin A deficiency and mutations of RXRα, RXRβ, and RXRα lead to early differentiation of embryonic ventricular cardiomyocytes
87. Maternal diseases affecting the fetal cardiovascular system
88. Controversies in tocolytic therapy
89. Fetal and neonatal cardiovascular complications from B-sympathomimetic therapy for tocolysis
90. Teratogenecity of anticonvulsant drugs. IV. The association of clefting and epilepsy
91. The effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios
92. Diabetes and fetal heart: Application of fetal echocardiography
93. The effect of ion exchange resisns in the paroxysmal disorders of the nervous system
94. Major and minor birth malformations and antiepileptic drugs
95. Congenital hyperthyroidism
96. Epilepsy in pregnancy
97. Rate and type of congenital anomalies among offspring of diabetic women
98. Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: The prospective P2C2 HIV Multicenter Study
99. Retonic acid embryopathy
100. Diabetes mellitus and pregnancy
101. Maternal phenylketonuria and hyperphenylalaninemia: An international survey of outcome of untreated and treated pregnancies
102. Mutagenecity, carcinogenecity, and teratogenecity of lithium compounds
103. Hemodynamic, pulmonary, vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus
104. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy paralleled by changes in patterns of malformations
105. Epilepsy of women in childbearing age
106. Teratogenic effects of antiepileptic drugs: Implications for the management of epilepsy in women of childbearing age
107. Neonatal lupus risk to newborns of mothers with systemic lupus erythematous
108. Type and frequency of cardiac defects in embryofetal alcohol syndrome. Report of 16 cases
109. Cardiac mobidity and related mortality in children with HIV infection
110. Assessment of fetal thyroid function by colored doppler echography
111. Stillbirth following maternal Lyme disease
112. Drugs in pregnancy: Anticonvulsants
113. Premature in utero closure of the ductus arteriousus following maternal ingestion of sodium diclofenac
114. Hyperthyroidism in pregnancy: Diagnosis and treatment
115. Neonatal lupus erythematous: A transplacentally acquired autoimmune disorder
116. Maternal and fetal outcome in neonatal lupus erythematosus
117. Pregnancy complicated by maternal heart disease: A review of 519 women
118. Clinical review 3: The clinical use of thyrotropin receptor antibody measurements
119. Fatal cardiomyopathy in an infant of a diabetic mother
120. Parvovirus B19 infection
121. Congenital heart block and associated cardiac pathology in neonatal lupus syndrome
122. Administration of prostaglandin inhibitors to the mother; the potential risk to the fetus and neonate with duct-dependent circulation
123. Antithyroid drug treatment of Graves' disease in pregnancy: Long-term effects on somatic growth, intellectual development and thyroid function in offspring
124. Hyperthyroidism in pregnancy
125. Thyroid disorders of pregnancy
126. Incidence of congenital heart defects in fetuses of diabetic mothers: A retrospective study of 326 cases
127. Maternal alcohol consumption and birthweight
128. Lack of relation of increased malforation rates in infants of diabetic mother to glycemic control during organogenesis
129. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use
130. Maternal hyperthyroidism and congenital malformation in the offspring
131. Hormones and epilepsy through the lifetime
132. Thyroid disease in women
133. Mumps virus and endocardial fibroelastosis
134. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection
135. Genetics and recurrence risks of congenital heart disease
136. Maternal seizure disorder, outcome of pregnancy and neurologic abnormalities in the children
137. From generational studies to a multilevel genetic-environmental interaction
138. Multifactorial inheritance hypothesis for the etiology of congenital heart disease: The genetic-environmental interaction
139. Teratogen update: Fetal effects of indomethacin administration during pregnancy
140. Neonatal complications after the administration of indomethacin for preterm labor
141. Ventricular septal thickness and cardiac function in neonates after in utero ritrodine exposure
142. Epidemiologic characteristics of conotruncal heart defects in California, 1987-1988
143. The risk of spina bifida aperta after first trimester valproate exposure in the prenatal cohort
144. Nonsteroidal anti-inflammatory drugs during pregnancy
145. Safety of non-steroidal anti-inflammatory drugs in a pregnant patient with rheumatic disease
146. Intrauterine virus infections and congenital heart disease
147. Toward a molecular understanding of congenital heart disease
148. Congenital rubella in the United Kingdom before 1970: The prevaccine era
149. Epilepsy
150. Systemic lupus erythematous
151. Hyperthyroidism in early infancy: Pathophysiology, clinical features, and diagnosis with a focus on neonatal hyperthyroidism
152. B19 parvovirus infection of myocardial cells
153. Pregnancy in cyanotic congenital heart disease: Outcome of mother and fetus
154. Anti-Ro (SSA) HLA-DR3-positive women: The interrelationship between serum ANA negayive, SS, SCLE, and NLE mothers and S/LE overlap female patients
155. Growth and function of human fetal heart in normal, hypertensive, and diabetic pregnancy
156. Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women
157. Metabolic fuel mixtures and diabetic embryopathy
158. Contraction of the fetal ductus arteriosus induced by doclofenac
159. Hypertrophic cardiomyopathy in infants of diabetic mothers: An update
160. Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers
161. Life-time prevalence of specific psychiatric disorders
162. Congenital rubella after anticipated maternal immunity: Two cases and review of the literature
163. Parvovirus infection
164. Management of parvovirus infection in pregnancy of hydrops: A survey of members of the society of perinatal obstetricians
165. Parvovirus B10 in fetal hydrops
166. Major congenital anomalies in infants and glycosylated hemoglobin levels in insulin-requiring diabetic mothers
167. Etiology of congenital heart disease
168. Teratogenecity of high vitamin A intake
169. Cardiovascular defects associated with alcohol, retinoic acid, and other agents
170. Chronic ethanol exposure in the embryonic chick heart: Effect on myocardial function and structure
171. Miscellaneous infections of the newborn
172. Use of cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery
173. Intrauterine management of fetal parvovirus B19 infection
174. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi
175. Outcome of pregnancy in women with congenital heart disease
176. The effect of pregnancy on the natural history of epilepsy: Review of the literature
177. Massive hypertrophic cardiomyopathy in infant of a diabetic mother
178. Connective tissue disease, autoantibodies to ribonucleoprotein and congenital heart block
179. Changes in fetal hemodynamics with terbutaline treatment and premature labor
180. Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers
181. Syphilis in pregnancy
182. The prognostic value of hemoglobin A1c in predieting fetal heart disease in diabetic pregnancies
183. Congenital malformations following chickenpox, measles, mumps, and hepatitis: Results of a cohort study
184. Role of vitamin A in the formation of congential heart defects
185. Lithium and ebstein's anomaly
186. Toxoplasmosis
187. Risk and predictors for pregnancy-related complications in women with heart disease
188. The woman with congenital heart disease
189. Systemic lupus erythematous and the skin
190. Maternal Lyme disease and congenital heart disease: A case-control study in an endemic area
191. Seizures, anticonvulsants, and pregnancy
192. Pregnancy and epilepsy
193. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
194. Diagnosis of fetal rubella infection with reverse transcriptase and nested polymerase chain reaction: A study of 34 cases diagnosed in fetuses
195. Fetal heart rate during maternal grand mal epileptic seizures
196. Pregnancy and heart disease: A review
197. Cardiac disease
198. Neonatal lupus syndromes
199. Acute fetal ductal occlusion in lambs
200. United Nations Development Programme: Young women: Silence, susceptibility, and the HIV epidemic
201. Congenital heart defects in children of human immunodeficiency virus-positive mothers
202. Aplasia cutis congenita after exposure to methimazole: A causal relationship?
203. Cardiac disease in congenital infections
204. Congenital heart disease and pregnancy
205. Risks and complications of tocolysis
206. Outcomes of pregnancy associated with antiepileptic drugs
207. The natural history of fetal cytomegalovirus infection as assessed by serial ultrasound and fetal blood sampling: A case report
208. The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers
209. The International Register of Lithium Babies
210. Cardiovascular malformations with lithium use during pregnancy
211. Pregnancy in women with disabilities
212. Prenatal diagnosis of fetal hyperthyroidism using funipucture
213. A second-generation study of 427 probands with congenital heart defects and their 837 children
214. Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen
215. Maternal Lyme disease and congenital malformations: A cord blood serosurvey in endemic and control areas
216. Choanal atresia and hypothelia following methimazole exposure in utero: A second report
217. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy
218. Cytomegalovirus myocarditis
219. Nutrition
220. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection: Report of 10 cases and meta-analysis
221. Pregnancy, teratogenesis, and epilepsy
222. Psychosocial and psychiatric issues
223. Management issues for women with epilepsy: A review of the literature
224. A case control study on the association between first trimester exposure to lithium and Ebstein's anomaly
225. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: A case report
226. Rubella infection during pregnancy in the 1985-86 epidemic: Follow-up after seven years
227. Maternal drugs and congenital heart disease
228. Fetal and neonatal hyperthyroidism
229. Inhibition of human premature labor by indomethacin